Alan T. Yeo
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 2
-
- Lung Cancer Treatments and Mutations 2
- Cancer Research top 5%
- NF-κB Signaling Pathways 3
- Cancer, Hypoxia, and Metabolism 2
- Immunology top 5%
- Immune cells in cancer 4
- Genetics top 10%
- Glioma Diagnosis and Treatment 4
-
- Natural product bioactivities and synthesis 3
- RNA modifications and cancer 1
- Co-authors
- Vassiliki A. BoussiotisAnthos ChristofidesLaura StraussAlain CharestCarol CaoJeffrey A. EngelmanMari Mino–KenudsonCyril H. Benes
- Partner nations
- United StatesAustralia
In The Last Decade
Alan T. Yeo
13 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 931
- Pulmonary and Respiratory Medicine 888
- Cancer Research 382
- Immunology 496
- Genetics 137
Countries citing papers authored by Alan T. Yeo
This map shows the geographic impact of Alan T. Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan T. Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan T. Yeo more than expected).
Fields of papers citing papers by Alan T. Yeo
This network shows the impact of papers produced by Alan T. Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan T. Yeo. The network helps show where Alan T. Yeo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan T. Yeo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 15 | |
| 3 | Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progressionbreakdown → | 2022 | 153 |
| 4 | The complex role of tumor-infiltrating macrophagesbreakdown → | 2022 | 560 |
| 5 | 2021 | 16 | |
| 6 | 2019 | 9 | |
| 7 | 2019 | 1 | |
| 8 | 2017 | 18 | |
| 9 | 2016 | 5 | |
| 10 | 2015 | 2 | |
| 11 | 2014 | 60 | |
| 12 | 2014 | 10 | |
| 13 | Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancersbreakdown → | 2012 | 976 |
| 14 | 2011 | 15 |
About Alan T. Yeo
Alan T. Yeo is a scholar working on Genetics, Cancer Research and Toxicology, having authored 14 papers that have together received 1.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), Immune cells in cancer (4 papers), Natural product bioactivities and synthesis (3 papers), NF-κB Signaling Pathways (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Treatments and Mutations (2 papers) and RNA modifications and cancer (1 paper). The work is most often cited by research in Oncology (931 citations), Pulmonary and Respiratory Medicine (888 citations) and Cancer Research (382 citations). Alan T. Yeo has collaborated with scholars based in United States and Australia. Frequent co-authors include Vassiliki A. Boussiotis, Anthos Christofides, Laura Strauss, Alain Charest, Carol Cao, Jeffrey A. Engelman, Mari Mino–Kenudson, Cyril H. Benes, Lecia V. Sequist and A. John Iafrate. Their work appears in journals such as Nature Immunology, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.